GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » E10

Yuhan (XKRX:000100) E10 : ₩1,455.28 (As of Mar. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Yuhan E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Yuhan's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩169.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩1,455.28 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Yuhan's average E10 Growth Rate was 4.60% per year. During the past 3 years, the average E10 Growth Rate was 4.90% per year. During the past 5 years, the average E10 Growth Rate was 0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Yuhan was 4.90% per year. The lowest was -6.50% per year. And the median was -3.50% per year.

As of today (2024-06-06), Yuhan's current stock price is ₩79600.00. Yuhan's E10 for the quarter that ended in Mar. 2024 was ₩1,455.28. Yuhan's Shiller PE Ratio of today is 54.70.

During the past 13 years, the highest Shiller PE Ratio of Yuhan was 53.19. The lowest was 17.28. And the median was 36.23.


Yuhan E10 Historical Data

The historical data trend for Yuhan's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan E10 Chart

Yuhan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,323.92 1,276.65 1,326.78 1,382.79 1,471.74

Yuhan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,391.38 1,373.57 1,395.28 1,471.74 1,455.28

Competitive Comparison of Yuhan's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Yuhan's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yuhan's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuhan's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Yuhan's Shiller PE Ratio falls into.



Yuhan E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yuhan's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=169/118.8477*118.8477
=169.000

Current CPI (Mar. 2024) = 118.8477.

Yuhan Quarterly Data

per share eps CPI Adj_EPS
201406 348.843 99.353 417.292
201409 334.223 99.608 398.780
201412 228.230 99.098 273.715
201503 323.935 99.720 386.070
201506 410.841 100.050 488.031
201509 591.828 100.110 702.601
201512 337.201 100.220 399.876
201603 675.621 100.560 798.488
201606 449.151 100.790 529.622
201609 317.302 101.460 371.680
201612 789.492 101.560 923.881
201703 389.738 102.850 450.359
201706 386.753 102.610 447.955
201709 349.087 103.490 400.891
201712 353.607 102.990 408.053
201803 276.995 104.100 316.236
201806 216.999 104.130 247.670
201809 142.826 105.650 160.668
201812 154.287 104.350 175.723
201903 39.020 104.490 44.382
201906 14.260 104.880 16.159
201909 37.766 105.200 42.665
201912 7.287 105.120 8.239
202003 290.908 105.540 327.589
202006 426.160 104.870 482.961
202009 381.734 106.200 427.196
202012 161.538 105.765 181.519
202103 259.151 107.357 286.888
202106 429.327 107.579 474.300
202109 302.343 108.759 330.388
202112 380.780 109.676 412.621
202203 201.361 111.806 214.043
202206 452.608 114.083 471.512
202209 99.773 114.831 103.263
202212 442.041 115.200 456.037
202303 281.905 116.550 287.464
202306 115.238 117.140 116.918
202309 260.952 119.111 260.375
202312 1,141.670 118.848 1,141.670
202403 169.000 118.848 169.000

Add all the adjusted EPS together and divide 10 will get our e10.


Yuhan  (XKRX:000100) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Yuhan's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=79600.00/1455.28
=54.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Yuhan was 53.19. The lowest was 17.28. And the median was 36.23.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Yuhan E10 Related Terms

Thank you for viewing the detailed overview of Yuhan's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Yuhan (XKRX:000100) Business Description

Traded in Other Exchanges
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000100) Headlines

No Headlines